Acetylcysteine increases sensitivity of ceftazidime-avibactam–resistant enterobacterales with different enzymatic resistance to ceftazidime-avibactam in vitro and in vivo

Abstract Background Ceftazidime-avibactam (CZA) improves treatment outcomes for infections caused by carbapenem-resistant organisms, but has led to serious bacterial resistance. Acetylcysteine (NAC) is an approved medication that protects the respiratory tract through antioxidant and anti-inflammato...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Zeyu Huang, Yijia Han, Xiaotuan Zhang, Yao Sun, Yuzhan Lin, Luozhu Feng, Tieli Zhou, Zhongyong Wang
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2023-11-01
Serija:	BMC Microbiology
Teme:	Enterobacterales Ceftazidime-avibactam Antimicrobial resistance Acetylcysteine
Online dostop:	https://doi.org/10.1186/s12866-023-03068-5
Oznake:	Označite Brez oznak, prvi označite!